Clinical Trials in Los Angeles

Showing 15601-15620 of 16,901 trials

CP-675,206 In Patients With Advanced Melanoma

NCT00086489

The purpose of this study is to assess the efficacy, safety, and tolerability of monoclonal antibody therapy using 2 regimens for the treatment of advanced melanoma

Malignant Melanoma

AstraZeneca118 participantsStarted Aug 2003

Los Angeles, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +6 more locations

COMPLETEDPhase 2< 1 mile

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

NCT00023413

The aim of this trial is to study the efavirenz-rifabutin interaction. Thus, this trial will enroll patients with HIV and tuberculosis co-infections who are receiving a rifabutin-based regimen and who plan to begin an antiretroviral regimen containing efavirenz dosed at 600 mg daily. Enrollment in TB Trials Consortium Study 23 is not a requirement for participation in this study. Primary Objective: To compare the pharmacokinetics of rifabutin at 600 mg twice a week in combination with efavirenz 600 mg daily to the pharmacokinetics of rifabutin 300 mg twice a week without efavirenz.

HIV InfectionsTuberculosis

Centers for Disease Control and Prevention20 participantsStarted Nov 1999

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +20 more locations

CP-675,206 In Patients With Advanced Melanoma

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Find Trials by Condition in Los Angeles

Comparative Study of Laparoscopic Versus Open Appendectomy in Children

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Patient Satisfaction of Cervical Ripening in an Outpatient Setting

A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain

Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels

A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss

Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia

Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

A Study for Treatment of Pain in Patients With Diabetic Neuropathy.

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period